- Home
- CTRM vs MODD Comparison
CTRM vs MODD Comparison
Compare CTRM & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTRM | MODD |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | Cyprus | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 23.5M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CTRM | MODD |
|---|---|---|
| Price | $1.93 | $3.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 40.6K | 20.7K |
| Earning Date | 04-15-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.62 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.66 | $0.12 |
| 52 Week High | $2.65 | $6.16 |
Technical Indicators
Market Signals| Indicator | CTRM | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 48.87 | 43.12 |
| Support Level | $1.85 | $0.41 |
| Resistance Level | $2.17 | $6.04 |
| Average True Range (ATR) | 0.08 | 0.39 |
| MACD | -0.01 | -0.17 |
| Stochastic Oscillator | 26.92 | 19.26 |
Price Performance
Historical ComparisonAbout CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.